Yahoo Web Search

Search results

1. • Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded by StockNews.com to “Buy”

     ETF DAILY NEWS· 3 days ago

     Several other equities research analysts have also recently commented on TEVA. JPMorgan Chase & Co. raised Teva Pharmaceutical Industries ...

2. • 

     Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...

     GuruFocus.com via Yahoo Finance· 7 days ago

     On May 16, 2024, Amir Weiss, the Chief Accounting Officer of Teva Pharmaceutical Industries Ltd...

3. • Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know - Teva Pharmaceutical Indus (NYSE:...

     Benzinga· 2 days ago

     Loading... Loading... Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus TEVA . And retail ...

4. • 

     Big Pharma Teva Accused of Delaying Generic Drug Competition | Connecticut Law Tribune

     Law.com· 2 days ago

     Lawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to...

5. • Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

     Morningstar· 3 days ago

     Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA

6. • Teva- Pharmaceutical Industries Ltd. ADR (TEVA) receives a Neutral rating from JP Morgan – Knox...

     Knox Daily· 4 days ago

     In a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 million ...

7. • Compatibility issues found with autoinjectors, FDA says

     Becker’s Hospital Review· 7 days ago

     If some autoinjectors are used with glatiramer acetate injections, there is an increased risk for medication errors, including a missed dose or partial administration, the agency said May 16 ...

8. • 

     Amphastar maintains stock target on AMP-008 FDA approval By Investing.com

     Investing.com· 13 hours ago

     On Thursday, Piper Sandler confirmed its Overweight rating and a $71.00 stock price target for...

9. • JD Supra: Federal Circuit Patent Watch: District Court’s “Seemingly Siloed and Inflexible Approach”...

     JD Supra· 8 hours ago

     Prost, J. The Court affirmed the district court’s indefiniteness determination but vacated and remanded its nonobviousness determination as to the asserted patent. Regarding obviousness, the ...

10. • 10 drugs now in shortage

      Becker’s Hospital Review· 2 days ago

      About a month after the number of ongoing drug shortages reached a 23-year record, more than four dozen patient advocacy groups wrote to legislators, urging them to address the shortages. A ...